The primary antibodies used included anti-ZO-1 (Abcam, ab307799, 1:5000), anti-Occludin (Abcam, ab216327, 1:5000), anti-ACSL4 (Abcam, ab155282, 1:10000), anti-TFR1 (ABclonal, A5865, 1:2000), anti-SLC7 A11 (Abcam, ab175186, 1:5000), anti-GPX4 (Abcam, ab125066, 1:5000), anti-VDAC2 (Proteintech, 116631-AP, 1:5000), anti-VDAC3 (Proteintech, 552601-AP, 1:5000), -tubulin (Proteintech, 100681-AP, 1:5000), and GAPDH (Proteintech, 104941-AP, 1:20000)
In general, these blends are discussed as different pathway-focused options rather than required combinations
Be cautious with mystery "detox" stacks sold online
It makes protocol design more important, not less
If you are like most people with thyroid disease then the answer is yes
One of the largest cohort studies of GDH-HI patients monitoring neurological prognosis [23] showed that children who displayed a symptom within the first 3 months after birth had light to mild developmental retardation and had a seizure occurrence rate higher than 70%